American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$416M |
| 2 |
PepsiCo
PEP
|
+$370M |
| 3 |
Aptiv
APTV
|
+$289M |
| 4 |
Johnson & Johnson
JNJ
|
+$283M |
| 5 |
NXP Semiconductors
NXPI
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$339M |
| 2 |
INXN
Interxion Holding N.V.
INXN
|
+$320M |
| 3 |
Apple
AAPL
|
+$239M |
| 4 |
Booz Allen Hamilton
BAH
|
+$236M |
| 5 |
Roper Technologies
ROP
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Financials | 16.35% |
| 3 | Healthcare | 15.09% |
| 4 | Consumer Discretionary | 11.64% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Bristol-Myers Squibb
BMY
$130B
| $248M | 0.24% |
3,862,541
+2,198,969
| +132% | +$126M |
|
127
JB Hunt Transport Services
JBHT
$25.3B
| $248M | 0.24% |
2,121,697
-17,440
| -0.8% | -$2M |
|
128
Vertex Pharmaceuticals
VRTX
$134B
| $247M | 0.23% |
1,125,864
+135,987
| +14% | +$27.5M |
|
129
Aflac
AFL
$60.5B
| $246M | 0.23% |
4,643,421
-149,225
| -3% | -$7.92M |
|
130
Intel
INTC
$509B
| $244M | 0.23% |
4,076,149
-2,545,075
| -38% | -$142M |
|
131
Baxter International
BAX
$13.8B
| $244M | 0.23% |
2,916,445
+410,819
| +16% | +$34M |
|
|
PXD
132
DELISTED
Pioneer Natural Resource Co.
PXD
| $243M | 0.23% |
1,604,831
+58,002
| +4% | +$7.72M |
|
133
Enterprise Products Partners
EPD
$82.1B
| $235M | 0.22% |
8,346,159
+395,758
| +5% | +$10.7M |
|
134
TE Connectivity
TEL
$61.9B
| $233M | 0.22% |
2,430,952
+182,783
| +8% | +$16.9M |
|
135
Cardinal Health
CAH
$55.1B
| $231M | 0.22% |
4,570,580
-198,420
| -4% | -$10.2M |
|
136
First Hawaiian
FHB
$3.35B
| $226M | 0.22% |
7,845,252
+519,991
| +7% | +$14.6M |
|
137
Elanco Animal Health
ELAN
$11B
| $223M | 0.21% |
7,563,826
-1,556,435
| -17% | -$42.3M |
|
138
Avantor
AVTR
$9.22B
| $220M | 0.21% |
12,111,887
+2,205,780
| +22% | +$35.1M |
|
|
CTLT
139
DELISTED
CATALENT, INC.
CTLT
| $218M | 0.21% |
3,870,397
+629,268
| +19% | +$32.1M |
|
140
Cheniere Energy
LNG
$55.2B
| $216M | 0.21% |
3,531,849
+215,724
| +7% | +$13.3M |
|
141
CoStar Group
CSGP
$12.4B
| $214M | 0.2% |
3,580,000
-434,960
| -11% | -$25.4M |
|
142
McKesson
MCK
$104B
| $213M | 0.2% |
1,539,991
+248,362
| +19% | +$35.1M |
|
143
Honeywell
HON
$73B
| $213M | 0.2% |
1,276,227
+139,264
| +12% | +$22.8M |
|
144
Gilead Sciences
GILD
$169B
| $213M | 0.2% |
3,272,399
-392,498
| -11% | -$25.6M |
|
145
Credicorp
BAP
$30B
| $212M | 0.2% |
992,506
+55,337
| +6% | +$11.6M |
|
146
Netflix
NFLX
$308B
| $211M | 0.2% |
6,507,920
-5,010,650
| -44% | -$149M |
|
147
Liberty Media Series C
FWONK
$25.9B
| $210M | 0.2% |
4,716,817
-54,440
| -1% | -$2.27M |
|
|
BDXA
148
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
| $209M | 0.2% |
3,191,268
+894,430
| +39% | +$55.4M |
|
149
Eversource Energy
ES
$26.8B
| $208M | 0.2% |
2,444,487
-704,975
| -22% | -$58.6M |
|
150
Baker Hughes
BKR
$64.4B
| $207M | 0.2% |
8,089,100
-3,741,430
| -32% | -$85.1M |
|
Similar funds
American Century Companies's Q4 2019 Portfolio in Review
As of Q4 2019, American Century Companies held 1,608 positions worth $105B, up 5.4% from $99.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
American Century Companies's Q4 2019 filing shows 405 new, 473 increased, 604 reduced and 116 closed positions. Its largest new stake was NXP Semiconductors: 2,360,390 shares worth $300M. The largest sale was iShares Russell 1000 Value ETF, an estimated $339M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2019 buy was NXP Semiconductors: 2,360,390 shares worth $300M.
- American Century Companies added most to Texas Instruments in Q4 2019, an estimated $416M increase.
- American Century Companies's biggest Q4 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $339M.
- American Century Companies fully exited Celgene Corp in Q4 2019, selling an estimated $127M.
- American Century Companies's ten largest holdings make up 19% of its $105B portfolio in Q4 2019.
- American Century Companies opened 405 new positions and closed 116 in Q4 2019.
- American Century Companies's portfolio value rose 5.4% quarter-over-quarter to $105B.
Based on American Century Companies's 13F filing for Q4 2019, filed 12 Feb 2020.